Trial Details
Not recruitingBasic Information
| Clinical ID | c3309 |
|---|---|
| Identifier | NCT00810004 |
| Trial Title | A Multi-centre, Randomised, Prospective, Single-blinded, Controlled Study to Investigate the Efficacy and Safety of a Standardised Maintenance Dosage Regimen of Intravenous Ferric Carboxymaltose (FERINJECT) Versus Placebo in Patients With Iron Deficiency Caused by Inflammatory Bowel Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | No results available |
|---|---|
| Conditions | Iron Deficiency;Inflammatory Bowel Disease |
| Interventions | Drug: Ferinject |
Participant Information
| Sponsor | Vifor Inc. |
|---|---|
| City | - |
| Country/Region | Russia |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | - |
Study Design
| Study Type | Interventional |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2025-04-24 |
|---|---|
| Primary Completion Date | - |
| Completion Date | - |